| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 01/07/2009 | CN101337035A Traditional Chinese preparation with bacteriostatic action for preventing blood sugar rising and preparation method thereof |
| 01/07/2009 | CN101337022A Oral preparation capable of reducing blood fat and blood pressure, nourishing the heart and protecting brain and preparation method thereof |
| 01/07/2009 | CN101337009A Use of water hyacinth extract in preparing lipid-lowering medicine |
| 01/07/2009 | CN101337001A Solanum xanthocarpum extract, preparation method and use thereof |
| 01/07/2009 | CN101337000A Solanum nigrum extract, preparation method and use thereof |
| 01/07/2009 | CN101336974A Traditional Chinese medicine for reducing blood sugar and regulating lipid with overall regulation of body metabolism and preparation method thereof |
| 01/07/2009 | CN101336965A Chinese prepared medicine for improving sugar tolerance and reducing blood sugar and preparation method thereof |
| 01/07/2009 | CN101336964A Mulberry bark extract capable of reducing blood sugar and preparation method thereof |
| 01/07/2009 | CN101336962A Ixeri sonhifolia decoction preparation technique |
| 01/07/2009 | CN101336943A Evening primrose oil liquid capsule capable reducing blood sugar, blood fat and weight and preparation method thereof |
| 01/07/2009 | CN101336935A Sea cucumber extract and preparation method thereof |
| 01/07/2009 | CN101336931A Iron liposomes used as iron supplementary and preparation method thereof |
| 01/07/2009 | CN101336922A Rosuvastatin amlodipine composition |
| 01/07/2009 | CN101336921A Rosuvastatin azelnidipine composition |
| 01/07/2009 | CN101336920A Stable medicine combination |
| 01/07/2009 | CN101336905A Production method of alpha-linolenic acid microcapsule |
| 01/07/2009 | CN101336904A Acarbose chewable tablets and preparation method thereof |
| 01/07/2009 | CN101336884A Preparation method of microelement nano fibrofelt |
| 01/07/2009 | CN101336723A Health food for relieving physical fatigue |
| 01/07/2009 | CN101336708A Soya-bean polypeptides weight reduction food |
| 01/07/2009 | CN101336705A Health food and its preparation method |
| 01/07/2009 | CN101336671A Low-fat freezing beverage and preparation method thereof |
| 01/07/2009 | CN100448994C Isolated nucleic acid molecules which encode T cell inducible factors, or interleukin-21, proteins encoded, and uses thereof |
| 01/07/2009 | CN100448887C Triterpene compound concentrate |
| 01/07/2009 | CN100448875C Substituted 1-piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof |
| 01/07/2009 | CN100448874C N-aroyl cyclic amines |
| 01/07/2009 | CN100448870C 2-aminoquinoline derivative |
| 01/07/2009 | CN100448869C Anilinopyrazole derivatives useful for the treatment of diabetes |
| 01/07/2009 | CN100448458C Composition of bleeding liquor of bitter melon, preparation method and usage |
| 01/07/2009 | CN100448453C A method of treating or preventing chronic wounds and a complete nutritional composition comprising glycine and/or leucine for use therein |
| 01/07/2009 | CN100448446C Buckthorn extract, its preparing method and use in pharmaceutical process |
| 01/07/2009 | CN100448374C Reducer of blood glucose level increase, reducer of body fat accumulation and food material |
| 01/07/2009 | CN100448358C Oil/fat composition |
| 01/06/2009 | US7473779 e.g. 2-amino-N-(4-{[amino(2-thienyl)methylidene]amino}phenethyl)-5-methoxybenzamide; nitric oxide NO-synthase enzymes inhibitor; selective or non selective traps for reactive oxygen species; antiproliferative, antiinflammatory agent |
| 01/06/2009 | US7473771 Nucleotide sequences coding recombinant protein for use in prevention and treatment of hyperphosphatemia |
| 01/06/2009 | US7473703 e.g. N-(4-{1-Hydroxy-1-[1-(2-methoxyethyl)-1H-pyrrol-2-yl]-ethyl}-phenyl)-N-methyl-benzenesulfonamide; liver X receptor (LXR) agonist; antidiabetic, antiproliferative agent; lipid, metabolic disorders, obesity, diabetes, hypercholesterolemia, atherosclerosis, hyperlipoproteinemia |
| 01/06/2009 | US7473698 Secondary amino anilinic piperidines as MCH1 antagonists and uses thereof |
| 01/06/2009 | US7473420 Processing adipose tissue to deliver a concentrated amount of stem cells in a closed system so that the stem cells are not exposed to external environment by use of a pre-assembled, linked set of closed, sterile containers and tubing allowing for transfer of tissue and fluid elements within a closed path |
| 01/06/2009 | CA2478374C N3 alkylated benzimidazole derivatives as mek inhibitors |
| 01/06/2009 | CA2421267C Fad4, fad5, fad5-2, and fad6, novel fatty acid desaturase family members and uses thereof |
| 01/06/2009 | CA2388957C Aromatic di-keto derivatives as glucose-6-phosphate translocase inhibitors |
| 01/06/2009 | CA2379086C 1,4,5,6-tetrahydropyrimidine derivative as a vitronectin inhibitor |
| 01/06/2009 | CA2369504C Pyrazole compositions useful as inhibitors of erk |
| 01/06/2009 | CA2266409C Mouthwash comprising calcium and phosphate ions in supersaturated solution |
| 01/06/2009 | CA2177007C Fluorophenyl-substituted alkenylcarboxylic acid guanidides, process for their preparation, their use as a medicament or diagnostic, and medicament containing them |
| 01/01/2009 | US20090005456 Phenyl substituted cycloalkylamines as monoamine reuptake inhibitors |
| 01/01/2009 | US20090005447 Methods, compounds, and compositions for reducing body fat and modulating fatty acid metabolism |
| 01/01/2009 | US20090005437 Alpha-Ketoglutarates and Their Use as Therapeutic Agents |
| 01/01/2009 | US20090005435 Novel Compounds, Pharmaceutical Compositions Containing Same, and Methods of Use for Same |
| 01/01/2009 | US20090005434 Novel Salicylic Anilides |
| 01/01/2009 | US20090005417 Substituted Indazolyl Sulfonamide and 2,3-Dihydro-Indolyl Sulfonamide Compounds, their Preparation and Use in Medicaments |
| 01/01/2009 | US20090005404 Pyridylsulfonamido pyrimidines for treating diabetic nephropathy |
| 01/01/2009 | US20090005391 Tricyclo Substituted Amides |
| 01/01/2009 | US20090005390 Novel quinuclidine derivatives and their use |
| 01/01/2009 | US20090005383 Thyroid hormone analogs |
| 01/01/2009 | US20090005375 Acetyl coenzyme a carboxylase inhibitors |
| 01/01/2009 | US20090005361 Combination of Organic Compounds |
| 01/01/2009 | US20090005351 Hormone replacement therapy |
| 01/01/2009 | US20090005323 Cathepsin K Inhibitors and Obesity |
| 01/01/2009 | US20090005315 Vip Fragments and Methods of Use |
| 01/01/2009 | US20090005312 Novel glp-1 analogues linked to albumin-like agents |
| 01/01/2009 | US20090005299 Method For Producing Carboxy-Terminal-Amidified Peptides |
| 01/01/2009 | US20090005296 Ammonium/Ammonia Transporter |
| 01/01/2009 | US20090004672 17867, a novel human aminopeptidase |
| 01/01/2009 | US20090004307 Aloe Vera Extract, Method of Producing Aloe Vera Extract, and Hyperglycemia Improving Agent |
| 01/01/2009 | US20090004306 Composition for treatment of diabetes and maintaining healthy blood glucose levels |
| 01/01/2009 | US20090004295 Use of a chemically-stabilized chlorite solution for inhibiting an antigen-specific immune response |
| 01/01/2009 | US20090004238 Implantation of encapsulated biological materials for treating diseases |
| 01/01/2009 | US20090004237 B7-Like Molecules and Uses Thereof |
| 01/01/2009 | US20090004220 Compositions of Plant Carbohydrates as Dietary Supplements |
| 01/01/2009 | US20090004195 Somatostatin receptor antagonists and glucose control or hypoglycemia |
| 01/01/2009 | US20090004193 Diagnostics and Therapeutics for Diseases Associated With Vasoactive Intestinal Peptide Receptor 1 (Vpac1) |
| 01/01/2009 | US20090004181 Method for Modulating Appetite |
| 01/01/2009 | US20090004159 Polymerized Hemoglobin Media and Its Use in Isolation and Transplantation of Islet Cells |
| 01/01/2009 | US20090004156 POLYNUCLEOTIDES AND POLYPEPTIDES OF THE IFNalpha17 GENE |
| 12/31/2008 | WO2009001915A1 Substituted imidazole compound and use thereof |
| 12/31/2008 | WO2009001817A1 COMPOUND HAVING 11β-HSD1 INHIBITORY ACTIVITY |
| 12/31/2008 | WO2009000935A1 Slimming composition |
| 12/31/2008 | WO2009000552A2 Compositions for the treatment of hyperphenylalaninemia |
| 12/31/2008 | WO2009000296A2 Tpp ii inhibitors for use in the treatment of autoimmune and inflammatory diseases and transplant rejection |
| 12/31/2008 | WO2009000087A1 Substituted fused pyrimidines as antagonists of gpr105 activity |
| 12/31/2008 | WO2008127399A3 Azaindole derivatives as cftr modulators |
| 12/31/2008 | WO2008120214A3 Compositions containing phosphatidylserine in treating diabetes associated conditions |
| 12/31/2008 | WO2008116648A3 Novel glp-1 fusion peptides, their production and use |
| 12/31/2008 | WO2008113862A3 Composition useful for the prevention of type 2 diabetes and its complications in pre-diabetic patients with insulin resistance |
| 12/31/2008 | WO2008040995A9 Indazoles for use as dpp-iv inhibitors |
| 12/31/2008 | WO2008023278A8 1alpha-hydroxy-2- (3 ' -hydroxypropylidene) -19-n0r- vitamin d compounds with a 1,1-dimethylpropyl side chain |
| 12/31/2008 | WO2008013955A3 Sustained release formulations for pulmonary delivery |
| 12/31/2008 | EP2009011A1 Nitrogen-containing heterocyclic compound |
| 12/31/2008 | EP2009010A1 Cocrystal of c-glycoside derivative and l-proline |
| 12/31/2008 | EP2008994A1 New crystalline form IV of agomelatine, method of preparing same and pharmaceutical compositions containing same |
| 12/31/2008 | EP2008993A1 New crystalline form III of agomelatine, method of preparing same and pharmaceutical compositions containing same |
| 12/31/2008 | EP2008662A1 Lypolysis promoter |
| 12/31/2008 | EP2008656A1 Compositions for the treatment of hyperphenylalaninemia |
| 12/31/2008 | EP2008654A1 3-amino-thieno[2,3-b]pyridine-2-carboxylic acid amides |
| 12/31/2008 | EP2008649A1 Spill resistant pharmaceutical compositions |
| 12/31/2008 | EP2008532A1 Method for production of capsinoid-containing beverage/food |
| 12/31/2008 | EP2007729A1 Substituted tetrahydroisoquinoline compounds, their preparation and use in medicaments |
| 12/31/2008 | EP2007723A2 Organic compounds |
| 12/31/2008 | EP2007722A1 Adamantane derivatives for the treatment of the metabolic syndrome |